What Happened
Tara Pharmacy SE, LLC, a specialty pharmacy in Homewood, Alabama serving long-term care facilities, agreed in July 2022 to pay $622,000 to resolve allegations under the Controlled Substances Act and False Claims Act. The settlement addressed allegations that it filled Schedule II prescriptions lacking a valid, original physician signature and failed to obtain written prescriptions within seven days after an emergency dispense, and allegedly submitted false Medicare claims for those drugs. Two former employees brought the claims as whistleblowers and received $52,000. There was no determination of liability.
“Tara Pharmacy SE, LLC has agreed to pay the United States $622,000 to resolve allegations that it violated the Controlled Substances Act”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.